Main competitors
Consensus Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Objective/dr gap Nbr of analysts
- US$9.611 +69.81% 9
Average 9.61 +69.81% 9
Weighted average by Cap. 9.61 +69.81% 9
Bio Therapeutic Drugs